Author

Kevin Bumpers

Observed names: K. Bumpers, Kevin W. Bumpers

Institutions: Emory University, Winship Cancer Institute

Observed institutions: Emory University, Winship Cancer Institute

OpenAlex ID: A5074064801

Examining Racial Disparities in Colorectal Cancer Care

2009 · Jamillah Berry, Kevin Bumpers, et al. · Journal of Psychosocial Oncology · 93

Examining racial differences in diffuse large B-cell lymphoma presentation and survival

2012 · Christopher R. Flowers, Pareen J. Shenoy, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 57

A black‐white comparison of the quality of stage‐specific colon cancer treatment

2009 · Jamillah Berry, Lee Caplan, et al. · Cancer · 24

Development of the Lymphoma Enterprise Architecture Database: A caBIG ™ Silver Level Compliant System

2009 · Taoying Huang, Pareen J. Shenoy, et al. · Cancer Informatics · 21

A phase 1 dose escalation study of bortezomib combined with rituximab, cyclophosphamide, doxorubicin, modified vincristine, and prednisone for untreated follicular lymphoma and other low‐grade B‐cell lymphomas

2012 · Rajni Sinha, Jonathan L. Kaufman, et al. · Cancer · 20

Black/White Differences in the Treatment and Outcomes of Diffuse Large B Cell Lymphoma: A Matched Cohort Analysis.

2009 · Pareen J. Shenoy, Kevin Bumpers, et al. · Blood · 11

Vinorelbine, Paclitaxel, Etoposide, Cisplatin, and Cytarabine (VTEPA) Is an Effective Second Salvage Therapy for Relapsed/Refractory Hodgkin Lymphoma

2013 · Rajni Sinha, Pareen J. Shenoy, et al. · Clinical Lymphoma Myeloma & Leukemia · 10

Patterns of Social Support Among Lymphoma Patients Considering Stem Cell Transplantation

2011 · Roni Glover, Pareen Jaideep Shenoy, et al. · Social Work in Health Care · 5

Racial Differences in the Presentation and Outcomes of Diffuse Large B-Cell Lymphoma in the United States.

2009 · Neha Malik, Pareen J. Shenoy, et al. · Blood · 5

Racial Disparities in Cell of Origin Among DLBCL Patients.

2012 · Christopher R. Flowers, Loretta Nastoupil, et al. · Blood · 3

Vinorelbine, Paclitaxel, Etoposide, Cisplatin and Cytarabine (VTEPA) Is An Effective Salvage Therapy for Relapsed/Refractory (R/R) Hodgkin Lymphoma (HL) but Not for R/R Diffuse Large B Cell Lymphoma (DLBCL)

2011 · Rajni Sinha, Nassoma King, et al. · Blood · 2

The Addition of Bortezomib to Modified R-CHOP as Initial Therapy for Follicular NHL Results in High CR Rate and Is Well Tolerated.

2009 · Rajni Sinha, Jonathan L. Kaufman, et al. · Blood · 2

Examining the Racial Disparities In Presentation and Treatment for Patients with Diffuse Large B-Cell Lymphoma (DLBCL).

2010 · Pareen J Shenoy, Uma Borate, et al. · Blood · 1

Bortezomib plus modified R-CHOP as initial therapy for indolent B-cell lymphomas: Phase I results

2009 · C. Flowers, R. Sinha, et al. · Journal of Clinical Oncology · 1

Use of Rituximab with CHOP Chemotherapy Appears to Overcome Racial Disparities In Survival In Black Patients with Diffuse Large B Cell Lymphoma When Compared to CHOP Chemotherapy Alone.

2010 · Uma Borate, Pareen J Shenoy, et al. · Blood

Assessing disparities in treatment outcomes for patients with diffuse large B-cell lymphoma

2007 · Christopher R. Flowers, Pareen J. Shenoy, et al. · Cancer Epidemiology and Prevention Biomarkers

Works count: 16

Citation count: 255

H-index: 7

I10-index: 7